Boon Cher Goh

17.1k citations
227 papers · 8.8k indexed · 4 hit papers · h-index 53

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
  • Oncology top 0.5%
    • Drug Transport and Resistance Mechanisms

Papers in

    • Head and Neck Cancer Studies 17
    • Cancer Immunotherapy and Biomarkers 18
    • Colorectal Cancer Treatments and Studies 17
    • Cancer Treatment and Pharmacology 16

Boon Cher Goh

218 papers receiving 8.7k citations

Hit Papers

Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy 2025 · 22 citations
222016202620192022100200300400

Peers

Boon Cher Goh
Comparison fields: 5 of 146
  • Cancer Research 1.7k
  • Oncology 3.1k
  • Pharmacology 880
  • Otorhinolaryngology 343
  • Toxicology 224
Replace Daniel P. Normolle with:
Daniel P. Normolle United States
Merrill J. Egorin United States
Massimo Libra Italy
Alwin D. R. Huitema Netherlands
Gary J. Kelloff United States
Ron H.J. Mathijssen Netherlands
Gabriella Ferrandina Italy
Prashanth Rawla United States
Ricky A. Sharma United Kingdom
G. Milano France
Boon Cher Goh relative to Daniel P. Normolle United States Daniel P. Normolle's profile →
Citations per field
00.5×2.8×
Daniel P. Normolle · 1×
Citations per year

Countries citing papers authored by Boon Cher Goh

Since Specialization
Citations

This map shows the geographic impact of Boon Cher Goh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boon Cher Goh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boon Cher Goh more than expected).

Fields of papers citing papers by Boon Cher Goh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boon Cher Goh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boon Cher Goh. The network helps show where Boon Cher Goh may publish in the future.

Co-authors

The 25 scholars most cited alongside Boon Cher Goh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Boon Cher Goh Line = papers co-authored together Boon Cher Goh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20254
2 20243
3 20246
4 202412
5 202312
6 202312
7 202325
8 202267
9 202112
10 202148
11 202037
12 202012
13 201890
14 20187
15 20179
16 201682
17 201541
18 20155
19 20114
20 200641

About Boon Cher Goh

Boon Cher Goh is a scholar working on Otorhinolaryngology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pharmacology, having authored 227 papers that have together received 8.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (40 papers), Cancer Genomics and Diagnostics (19 papers), Cancer Immunotherapy and Biomarkers (18 papers), Cancer therapeutics and mechanisms (18 papers), Colorectal Cancer Treatments and Studies (17 papers), Head and Neck Cancer Studies (17 papers), Cancer Treatment and Pharmacology (16 papers) and Histone Deacetylase Inhibitors Research (15 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (3.1k citations), Pharmacology (880 citations), Otorhinolaryngology (343 citations) and Toxicology (224 citations). Boon Cher Goh has collaborated with scholars based in Singapore, United States and China. Frequent co-authors include Lingzhi Wang, Gautam Sethi, Alan Prem Kumar, Nicholas Syn, Jean Paul Thiery, Frank Arfuso, Muthu K. Shanmugam, Soo Chin Lee, Paul C. Ho and Ross A. Soo. Their work appears in journals such as Journal of Clinical Oncology, Cancer Letters, Annals of Oncology, Oncotarget and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026